Management of Malignant Pleural Effusions in US Veterans: A Retrospective Review

被引:1
|
作者
Mohs, Zachary [1 ]
DeVillers, Megan [1 ]
Ziegler, Stephanie [1 ]
Basson, Marc D. [2 ,4 ]
Newman, William [1 ,3 ]
机构
[1] UND, Sch Med & Hlth Sci, Dept Internal Med, Grand Forks, ND USA
[2] UND, Sch Med & Hlth Sci, Dept Surg, Grand Forks, ND USA
[3] Fargo Vet Affairs Med Ctr, Dept Internal Med, Fargo, ND USA
[4] UND, Sch Med & Hlth Sci, Dept Surg, 1301 N Columbia Rd, Grand Forks, ND 58203 USA
关键词
talc pleurodesis; indwelling pleural catheter; malignant pleural effusion; TALC PLEURODESIS; CATHETER; DYSPNEA;
D O I
10.5761/atcs.oa.22-00124
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To compare malignant pleural effusion (MPE) treatment outcomes and compli-cations among patients receiving indwelling pleural catheter (IPC), talc pleurodesis (TPS), or dual therapy. Outcomes were determined by measuring length of stay (LOS) and post-procedure dyspnea scores. Complications were measured by comparing intervention failures and adverse events.Methods: The Veterans Affairs' Corporate Data Warehouse was utilized to retrospectively review the charts of 314 MPE subjects. Dyspnea scores were estimated by researchers and LOS was determined by adding the duration of stay for all admissions post procedure. Complications were recorded through chart review.Results: IPC exhibited higher failure rates than the other approaches 1 year post inter-vention. Pneumonia/chest infection rate and lung entrapment were also more prevalent. There was no significant difference in dyspnea rates. LOS illustrated a significant differ-ence between groups, with talc patients spending a median of 7 days in the hospital immediately post procedure, while IPC and IPC + TPS patients spent a median of 3 and 2 days, respectively.Conclusion: Patients receiving IPC or combination treatment spend fewer days in the hospital than TPS patients. However, IPC appears to be associated with more adverse events and higher long-term failure rates than other management strategies.
引用
收藏
页码:420 / 428
页数:9
相关论文
共 50 条
  • [21] Management of malignant pleural effusions
    Spector, Marcelo
    Pollak, Jeffrey S.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 29 (04) : 405 - 413
  • [22] Management of malignant pleural effusions
    Lee, YCG
    Light, RW
    RESPIROLOGY, 2004, 9 (02) : 148 - 156
  • [23] Management of malignant pleural effusions
    Antunes, G
    Neville, E
    THORAX, 2000, 55 (12) : 981 - 983
  • [24] THE MANAGEMENT OF MALIGNANT PLEURAL EFFUSIONS
    MACKAY, JB
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1981, 11 (05): : 586 - 586
  • [25] Management of malignant pleural effusions
    Grossi, F
    Pennucci, MC
    Tixi, L
    Cafferata, MA
    Ardizzoni, A
    DRUGS, 1998, 55 (01) : 47 - 58
  • [26] Malignant Pleural Effusions A Review
    Thomas, Justin M.
    Musani, Ali I.
    CLINICS IN CHEST MEDICINE, 2013, 34 (03) : 459 - +
  • [27] Recent Developments in the Management of Malignant Pleural Effusions: a Narrative Review
    Coile, Clifford E.
    Harvey, Jessie G.
    Senitko, Michal
    CURRENT PULMONOLOGY REPORTS, 2020, 9 (04) : 164 - 170
  • [28] Recent Developments in the Management of Malignant Pleural Effusions: a Narrative Review
    Clifford E. Coile
    Jessie G. Harvey
    Michal Senitko
    Current Pulmonology Reports, 2020, 9 : 164 - 170
  • [29] SURGICAL MANAGEMENT OF MALIGNANT PLEURAL EFFUSIONS
    Wright, G.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) : S11 - S11
  • [30] MEDICAL MANAGEMENT OF MALIGNANT PLEURAL EFFUSIONS
    Lee, G.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) : S10 - S11